On August 23, 2020, the Board of Directors of Helius Medical Technologies, Inc. appointed Dane C. Andreeff as the company's Chief Executive Officer effective immediately. Mr. Andreeff succeeds Philippe Deschamps who stepped down from his roles as Chief Executive Officer of the company effective August 23, 2020 upon mutual agreement with the Board. Mr. Andreeff is expected to serve until the company completes a search and appoints a new Chief Executive Officer. Mr. Andreeff, age 54, has served as a member of Board of Directors since August 2017. Mr. Andreeff is the General Partner and Portfolio Manager at Maple Leaf Partners, LP, which owns approximately 3% of the Company's outstanding common stock. On August 25, 2020, the Company announced that the Board and Phillippe Deschamps had mutually agreed that Mr. Deschamps would step down from his positions as Chief Executive Officer of the Company effective August 23, 2020 (the Separation Date").